Cancer Research SABCS  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 58, 2919-2922, July 15, 1998]
© 1998 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abrahamson, J.
Right arrow Articles by Narod, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abrahamson, J.
Right arrow Articles by Narod, S. A.

No Association of the I1307K APC Allele with Ovarian Cancer Risk in Ashkenazi Jews1

John Abrahamson, Roxana Moslehi, Danny Vesprini, Beth Karlan, David Fishman, David Smotkin, Yehuda Ben David, Haim Biran, Abbie Fields, Jean-Sebastien Brunet and Steven A. Narod2

Women's College Hospital, The Centre for Research in Women's Health, Toronto, Ontario, M5G 1N8 Canada [J. A., R. M., D. V., J-S. B., S. A. N.]; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, V6H 3N1 Canada [R. M.]; Department of Obstetrics/Gynecology, Cedars Sinai Medical Center, Los Angeles, California 90048 [B. K.]; Department of Gynecologic Oncology, Prentice Women's Hospital, Chicago, Illinois 60611 [D. F.]; Department of Obstetrics and Gynecology, Long Island Jewish Hospital, New Hyde Park, New York 11040 [D. S.]; Department of Gynecologic Oncology, Central Emek Hospital, Haifa, Israel [Y. B. D.]; Institute of Oncology, Kaplan Hospital, Rehovot, Israel [H. B.]; and Division of Gynecologic Oncology, Albert Einstein College of Medicine, Bronx, New York 10461 [A. F.]

Familial adenomatous polyposis is a dominantly inherited colon cancer syndrome associated with germ-line mutations in the APC tumor suppressor gene. An APC gene sequence alteration, the 11307K allele, occurs in 6% of the Ashkenazi Jewish population and is reported to double the risk for colorectal cancer. We screened a population of 190 Ashkenazi women who were diagnosed with epithelial ovarian carcinoma for the 11307K variant and measured the effect of this allele on the risk for cancer development in their first-degree relatives. We identified the I1307K allele in 7.9% (15 of 190) of our ovarian cancer cases. The average age of ovarian cancer diagnosis in carriers of the I1307K allele (57.5 years) was not statistically different than the age for noncarriers (56.4 years; P = 0.70). Among the 1087 first-degree relatives, there were 23 cases of colorectal cancer; 3 of 100 relatives of probands with the I1307K allele (3.0%) had a history of colorectal cancer versus 20 of 987 relatives of probands without the I1307K allele (2.1%; relative risk, 1.48; 95% confidence interval, 0.45–4.88; P = 0.462). Relatives of the I1307K carriers had a risk of 38.0% for developing any cancer to age 80, similar to the risk for relatives of noncarriers of the I1307K allele (42.1%; P = 0.86). The average age of diagnosis of cancer of any type was not different between relatives of carriers (59.0 years) and noncarriers (60.4 years). In the Ashkenazi Jewish population, the I1307K allele is unlikely to increase the risk of ovarian cancer or of cancer in general.

1 This study was supported by NIH Grant IRO1 CA63678 and Department of the Army Grant DAMD 17-94-J-4299.

2 To whom requests for reprints should be addressed, at Center for Research in Women's Health, 790 Bay Street, Suite 750A, 7th Floor, Toronto, Ontario, M5G 1N8 Canada.

Received 3/24/98. Accepted 6/ 1/98.




This article has been cited by other articles:


Home page
J. Mol. Diagn.Home page
K. M. Murphy, T. Geiger, M. J. Hafez, J. R. Eshleman, C. A. Griffin, and K. D. Berg
A Single Nucleotide Primer Extension Assay to Detect the APC I1307K Gene Variant
J. Mol. Diagn., November 1, 2003; 5(4): 222 - 226.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
E. Karbova, B. Davidson, K. Metodiev, C. G. Trope, and J. M. Nesland
Adenomatous Polyposis Coli (APC) Protein Expression in Primary and Metastatic Serous Ovarian Carcinoma
International Journal of Surgical Pathology, July 1, 2002; 10(3): 175 - 180.
[Abstract] [PDF]


Home page
JAMAHome page
S. Syngal, D. Schrag, M. Falchuk, N. Tung, F. A. Farraye, D. Chung, M. Wright, A. Whetsell, G. Miller, and J. E. Garber
Phenotypic Characteristics Associated With the APC Gene I1307K Mutation in Ashkenazi Jewish Patients With Colorectal Polyps
JAMA, August 16, 2000; 284(7): 857 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
Z. Q. YUAN, N. WONG, W. D FOULKES, L. ALPERT, F. MANGANARO, C. ANDREUTTI-ZAUGG, R. IGGO, K. ANTHONY, E. HSIEH, M. REDSTON, et al.
A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening
J. Med. Genet., October 1, 1999; 36(10): 792 - 793.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.